retatrutide clinical trial results First phase 3 data, a Triumph of Science! retatrutide clinical trial data done!

Rather than harshly treating the hair, it works gently helping to nourish the scalp while improving the look and feel of your hair over time

Here is what has occurred and what patients may expect in the coming months based on manufacturer announcements and regulatory filings: December 22, 2025: FDA approved oral Wegovy (semaglutide 25 mg), the first oral GLP-1 for weight loss

We examined how medications like Ozempic, Wegovy, and Mounjaro can lead to accelerated facial aging through volume loss, collagen breakdown, and skin laxity

Individuals discontinuing second-line therapy for access/coverage-related reasons made fewer subsequent therapy changes compared to those who switched because of symptom or treatment-related reasons (2 vs